We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Evaluating the current level of pharmacists’ pharmacogenomics knowledge and its impact on pharmacogenomics implementation

    Mohamed Nagy

    *Author for correspondence:

    E-mail Address: Mohamed.Nagy@57357.com

    Department of Pharmaceutical Services, Personalised Medication Management Unit, Children’s Cancer Hospital Egypt (57357), Cairo, Egypt

    Authors contributed equally

    Search for more papers by this author

    ,
    Evangelia Eirini Tsermpini

    Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece

    Authors contributed equally

    Search for more papers by this author

    ,
    Stavroula Siamoglou

    Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece

    &
    George P Patrinos

    Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece

    Zayed Center of Health Sciences, United Arab Emirates University, Al-Ain, UAE

    Department of Pathology, College of Medicine & Health Sciences, United Arab Emirates University, Al-Ain, UAE

    Published Online:https://doi.org/10.2217/pgs-2020-0076

    The pharmacists’ role is potentially vital in the growing field of personalized medicine, and well-defined guidelines and knowledge that support this role need to be established. To address the knowledge gap, over the past two decades, pharmacy schools have started providing pharmacogenomics-related courses, a field that overlaps with pharmacy and personalized medicine. Given the fact that pharmacists lead 50% of the Clinical Pharmacogenetics Implementation Consortium implementers’ sites, their role can be particularly crucial to move forward the integration of precision medicine in clinical practice. Herein, we aim to identify the educational challenges for pharmacogenomics integration into clinical practice and their impact on pharmacists’ knowledge and confidence, in addition to underscoring pharmacists’ role in pharmacogenomics as a whole.

    References

    • 1. Rudis MI, Brandl KM. Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit. Care Med. 28(11), 3746–3750 (2000).
    • 2. Kogut SJ, Goldstein E, Charbonneau C, Jackson A, Patry G. Improving medication management after a hospitalization with pharmacist home visits and electronic personal health records: an observational study. Drug. Healthc. Patient Saf. 6, 1–6 (2014).
    • 3. Ratanajamit C, Kaewpibal P, Setthawacharavanich S, Faroongsarng D. Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs. J. Med. Assoc. Thai. 92(11), 1500–1507 (2009).
    • 4. Bishop MA, Streiff MB, Ensor CR, Tedford RJ, Russell SD, Ross PA. Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center. ASAIO J. 60(2), 193–198 (2014).
    • 5. DiDonato KL, May JR, Lindsey CC. Impact of wellness coaching and monitoring services provided in a community pharmacy. J. Am. Pharm. Assoc. 53(1), 14–21 (2013).
    • 6. Hogue MD, Grabenstein JD, Foster SL, Rothholz MC. Pharmacist involvement with immunizations: a decade of professional advancement. J. Am. Pharm. Assoc. 46(2), 168–182 (2006).
    • 7. Punekar Y, Lin SW, Thomas J. Progress of pharmacist collaborative practice: status of state laws and regulations and perceived impact of collaborative practice. J. Am. Pharm. Assoc. 43(4), 503–510 (2003).
    • 8. The American Society of Health-System Pharmacists. ASHP statement on the pharmacist’s role in clinical pharmacogenomics. Am. J. Health. Syst. Pharm. 72(7), 579–581 (2015).
    • 9. Burke JM, Miller WA, Spencer AP et al.; American College of Clinical Pharmacy. Clinical pharmacist competencies. Pharmacotherapy 28(6), 806–815 (2008).
    • 10. US FDA. Table of pharmacogenomic biomarkers in drug labeling. https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling
    • 11. Lin B, Chung WK. Cases in precision medicine: the role of pharmacogenetics in precision prescribing. Ann. Intern. Med. 170(11), 796–804 (2019).
    • 12. Owusu-Obeng A, Weitzel KW, Hatton RC et al. Emerging roles for pharmacists in clinical implementation of pharmacogenomics. Pharmacotherapy 34(10), 1102–1112 (2014).
    • 13. Kennedy MJ. Personalized medicines: are pharmacists ready for the challenge? Integr. Pharm. Res. Pract. 7, 113–123 (2018).
    • 14. Elewa H, Alkhiyami D, Alsahan D et al. A survey on the awareness and attitude of pharmacists and doctors towards the application of pharmacogenomics and its challenges in Qatar. J. Eval. Clin. Pract. 21(4), 703–709 (2015).
    • 15. AlEjielat R, Ejielat Z, Andrawes S, Mhaidat NM. An evaluation of the knowledge, opinions, expectations and concerns toward pharmacogenomics among Jordanian pharmacists. Per. Med. 13(2), 143–154 (2016).
    • 16. Reiss SM. Integrating pharmacogenomics into pharmacy practice via medication therapy management. J. Am. Pharm. Assoc. (2003). 51(6), e64–e74 (2011).
    • 17. McCullough KB, Formea CM, Berg KD et al. Assessment of the pharmacogenomics educational needs of pharmacists. Am. J. Pharm. Educ. 75(3), 51 (2011).
    • 18. Nagy M, Lynch M, Kamal S et al. Assessment of healthcare professionals’ knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt. Per. Med. 17(4), 251–260 (2020).
    • 19. Abdela OA, Bhagavathula AS, Gebreyohannes EA, Tegegn HG. Ethiopian health care professionals’ knowledge, attitude, and interests toward pharmacogenomics. Pharmgenomics Pers. Med. 10, 279–285 (2017).
    • 20. Albassam A, Alshammari S, Koshy S, Awad A, Ouda G. Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait. PLoS ONE 13(9), (2018).
    • 21. Yoshimachi S, Obara T, Goto T, Ramn Gutirrez Ubeda S, Abe S, Satoh M. Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists. Pharmgenomics Pers. Med. 8, 35–41 (2015).
    • 22. Gavi S, Matimba A, Nembaware V et al. Knowledge, attitude, and perceptions of pharmacists and pharmacy students towards pharmacogenomics in Zimbabwe. Pharmacy (Basel) 5(4), 36 (2017).
    • 23. Karas Kuželički N, Prodan Žitnik I, Gurwitz D et al. Pharmacogenomics education in medical and pharmacy schools: conclusions of a global survey. Pharmacogenomics 20(9), 643–657 (2019).
    • 24. Haga SB, Moaddeb J. Pharmacogenomics courses in pharmacy school curricula. Pharmacogenomics 20(9), 625–630 (2019).
    • 25. Lee KC, Hudmon KS, Ma JD, Kuo GM. Evaluation of a shared pharmacogenomics curriculum for pharmacy students. Pharmacogenomics 16(4), 315–322 (2015).
    • 26. Nutter SC, Gálvez-Peralta M. Pharmacogenomics: from classroom to practice. Mol. Genet. Genomic Med. 6(3), 307–313 (2018).
    • 27. Marcinak R, Paris M, Kinney SRMM. Pharmacogenomics education improves pharmacy student perceptions of their abilities and roles in its use. Am. J. Pharm. Educ. 82(9), 6424 (2018).
    • 28. Gálvez-Peralta M, Szklarz GD, Geldenhuys WJ, Lockman PR. An effective approach to teaching pharmacogenomics in the first year of pharmacy curriculum. Am. J. Pharm. Educ. 82(8), 6345 (2017).
    • 29. Weitzel KW, McDonough CW, Elsey AR, Burkley B, Cavallari LH, Johnson JA. Effects of using personal genotype data on student learning and attitudes in a pharmacogenomics course. Am. J. Pharm. Educ. 80(7), 122 (2016).
    • 30. Weitzel KW, Aquilante CL, Johnson S, Kisor DF, Empey PE. Educational strategies to enable expansion of pharmacogenomics-based care. Am. J. Heal. Pharm. 73(23), 1986–1998 (2016).
    • 31. Just KS, Steffens M, Swen JJ, Patrinos GP, Guchelaar HJ, Stingl JC. Medical education in pharmacogenomics: results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx). Eur. J. Clin. Pharmacol. 73(10), 1247–1252 (2017).
    • 32. Murphy JE, Green JS, Adams LA, Squire RB, Kuo GM, McKay A. Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States. Am. J. Pharm. Educ. 74(1), 7 (2010).
    • 33. Formea CM, Nicholson WT, McCullough KB et al. Development and evaluation of a pharmacogenomics educational program for pharmacists. Am. J. Pharm. Educ. 77(1), 10 (2013).
    • 34. Giri J, Curry TB, Formea CM, Nicholson WT, Rohrer Vitek CR. Education and knowledge in pharmacogenomics: still a challenge? Clin. Pharmacol. Ther. 103(5), 752–755 (2018).
    • 35. Pisanu C, Tsermpini E-E, Mavroidi E, Katsila T, Patrinos GP, Squassina A. Assessment of the pharmacogenomics educational environment in Southeast Europe. Public Health Genomics 17(5–6), 272–279 (2014).
    • 36. Rao US, Mayhew SL, Rao PS. Strategies for implementation of an effective pharmacogenomics program in pharmacy education. Pharmacogenomics 16(8), 905–911 (2015).
    • 37. Frick A, Benton C, Suzuki O et al. Implementing clinical pharmacogenomics in the classroom: student pharmacist impressions of an educational intervention including personal genotyping. Pharmacy (Basel) 6(4), 115–116 (2018).
    • 38. Remsberg CM, Bray BS, Wright SK et al. Design, implementation, and assessment approaches within a pharmacogenomics course. Am. J. Pharm. Educ. 81(1), 11 (2017).
    • 39. Patel RV, Chudow M, Vo TT, Serag-Bolos ES. Evaluation of pharmacy students’ knowledge and perceptions of pharmacogenetics before and after a simulation activity. Curr. Pharm. Teach. Learn. 10(1), 96–101 (2018).
    • 40. Tsermpini E-E, Stamopoulou T, Kordou Z et al. Continuous pharmacogenomics and genomic medicine education for healthcare professionals through electronic educational courses. Per. Med. 16(3), 189–193 (2019).
    • 41. ASHP. American Society of Health-System Pharmacists Residency online directory. https://accred.ashp.org/aps/pages/directory/residencyprogramsearch.aspx
    • 42. Haidar CE, Hoffman JM, Gammal RS, Relling MV, Crews KR. Development of a postgraduate year 2 pharmacy residency in clinical pharmacogenetics. Am. J. Heal. Pharm. 74(6), 409–415 (2017).
    • 43. Dunnenberger HM, Biszewski M, Bell GC et al. Implementation of a multidisciplinary pharmacogenomics clinic in a community health system. Am. J. Health. Syst. Pharm. 73(23), 1956–1966 (2016).
    • 44. Arnall JR, Petro R, Patel JN, Kennedy L. A clinical pharmacy pilot within a precision medicine program for cancer patients and review of related pharmacist clinical practice. J. Oncol. Pharm. Pract. 25(1), 179–186 (2019).
    • 45. Bain KT, Schwartz EJ, Knowlton OV, Knowlton CH, Turgeon J. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE). J. Am. Pharm. Assoc. (2003) 58(3), 281–289.e1 (2018).
    • 46. Bank PCD, Swen JJ, Schaap RD, Klootwijk DB, Baak-Pablo R, Guchelaar HJ. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care. Eur. J. Hum. Genet. 27(10), 1532–1541 (2019).
    • 47. Clinical Pharmacogenetics Implementation Consortium. List of PGx implementers who are using CPIC guidelines [Internet]. (2020). https://cpicpgx.org/implementation/
    • 48. Johnson JA, Bootman JL, Evans WE et al. Pharmacogenomics: a scientific revolution in pharmaceutical sciences and pharmacy practice. Report of the 2001–2002 Academic Affairs Committee. Am. J. Pharm. Educ. 66, 12S–15S (2002).
    • 49. Competency C, Group W, Coalition N et al. Recommendations of core competencies in genetics essential for all health professionals. Genet. Med. 3(2), 155–159 (2001).
    • 50. Roederer MW, Kuo GM, Diego S et al. Pharmacogenomics competencies in pharmacy practice: a blueprint for change. J. Am. Pharm. Assoc. (2003) 57(1), 120–125 (2017).
    • 51. Calzone KA, Jerome-D'Emilia B, Jenkins J et al. Establishment of the genetic/genomic competency center for education. J. Nurs. Scholarsh. 43(4), 351–358 (2011).
    • 52. Kisor DF, Pharm D. The DNA of pharmacy education: CAPE outcomes and pharmacogenomics table of contents. (2015). https://www.aacp.org/sites/default/files/%0A2017-10/The_DNA_of_Pharmacy_Education-CAPE_Outcomes_and_%0APharmacogenomics_2015.pdf